Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101459384 | 10145938 | 4 | F | 20130706 | 20160707 | 20140501 | 20160712 | EXP | PHHY2014PL051655 | NOVARTIS | KACZMARSKA-TUREK D, BARTNIK PJ, ORLEWSKI J. TOXIC EPIDERMAL NECROLYSIS IN PATIENT WITH MALIGNANT ASTROCYTOMA. 287 (88) | 62.00 | YR | M | Y | 0.00000 | 20160713 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101459384 | 10145938 | 1 | PS | TEGRETOL | CARBAMAZEPINE | 1 | Oral | 400 MG, BID | Y | 16608 | 400 | MG | TABLET | BID | |||||
| 101459384 | 10145938 | 2 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 2 MG, TID | U | 0 | 2 | MG | TID | ||||||
| 101459384 | 10145938 | 3 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 40 MG, QID | U | 0 | 40 | MG | QID | ||||||
| 101459384 | 10145938 | 4 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 0.125 MG, QID | U | 0 | .125 | MG | QID | ||||||
| 101459384 | 10145938 | 5 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25 MG, QID | U | 0 | 25 | MG | QID | ||||||
| 101459384 | 10145938 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 40 MG, QID | U | 0 | 40 | MG | QID | ||||||
| 101459384 | 10145938 | 7 | C | CLEMASTINUM | CLEMASTINE FUMARATE | 1 | Oral | 1 MG, QID | U | 0 | 1 | MG | QID | ||||||
| 101459384 | 10145938 | 8 | C | ENOXAPARIN | ENOXAPARIN | 1 | Subcutaneous | 100 MG, QID | U | 0 | 100 | MG | QID | ||||||
| 101459384 | 10145938 | 9 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 25 MG, TID | U | 0 | 25 | MG | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 101459384 | 10145938 | 1 | Epilepsy |
| 101459384 | 10145938 | 2 | Product used for unknown indication |
| 101459384 | 10145938 | 3 | Product used for unknown indication |
| 101459384 | 10145938 | 4 | Product used for unknown indication |
| 101459384 | 10145938 | 5 | Product used for unknown indication |
| 101459384 | 10145938 | 6 | Product used for unknown indication |
| 101459384 | 10145938 | 7 | Product used for unknown indication |
| 101459384 | 10145938 | 8 | Product used for unknown indication |
| 101459384 | 10145938 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 101459384 | 10145938 | HO |
| 101459384 | 10145938 | OT |
| 101459384 | 10145938 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 101459384 | 10145938 | Blister | |
| 101459384 | 10145938 | Conjunctivitis | |
| 101459384 | 10145938 | Dehydration | |
| 101459384 | 10145938 | Drug interaction | |
| 101459384 | 10145938 | Erythema | |
| 101459384 | 10145938 | Hyperaemia | |
| 101459384 | 10145938 | Mucosal haemorrhage | |
| 101459384 | 10145938 | Pyrexia | |
| 101459384 | 10145938 | Scab | |
| 101459384 | 10145938 | Staphylococcal sepsis | |
| 101459384 | 10145938 | Toxic epidermal necrolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 101459384 | 10145938 | 1 | 201305 | 201307 | 0 |